Results 281 to 290 of about 462,118 (388)

Right ventricular global work efficiency: A reliable non‐invasive estimate of right ventricular contractility

open access: yesESC Heart Failure, EarlyView.
The figure illustrates the study design and key findings related to right ventricular myocardial work (RVMW) in heart failure with reduced ejection fraction (HFrEF) patients with and without pulmonary hypertension (PH). Patients were stratified into two groups: those with PH (n = 53) and those without PH (n = 49), as determined by right heart ...
Paolo Manca   +12 more
wiley   +1 more source

Angiotensin receptor‐neprilysin inhibitors in concurrent heart failure with reduced ejection fraction and kidney failure

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Angiotensin receptor‐neprilysin inhibitor (ARNI) therapy has demonstrated improved outcomes in heart failure with reduced ejection fraction (HFrEF). However, its benefits in patients with concomitant kidney failure undergoing replacement therapy remain uncertain. Methods and results Using the National Health Insurance Service database, we
Mi‐Hyang Jung   +8 more
wiley   +1 more source

Increased Cerebrospinal Fluid Angiotensin-Converting Enzyme 2 Fragments as a Read-Out of Brain Infection in Patients With COVID-19 Encephalopathy. [PDF]

open access: yesJ Infect Dis
Lennol MP   +19 more
europepmc   +1 more source

Immuno‐haemostatic dysregulation in heart failure with preserved ejection fraction

open access: yesESC Heart Failure, EarlyView.
Abstract Aims Heart failure with preserved ejection fraction (HFpEF) is a complex condition with partially unclear pathophysiology, in which systemic inflammation is a central contributor to changes in cardiac structure and function. The contribution of non‐traditional immune effectors—such as platelets and coagulation—remains underexplored in HFpEF ...
Giorgia D'Italia   +13 more
wiley   +1 more source

Structure of Testicular Angiotensin-converting Enzyme

open access: hybrid, 1989
Rakesh Kumar   +4 more
openalex   +1 more source

Patient‐specific modifiers of survival benefit in cardiac resynchronization therapy ‐ A multicentre interaction analysis

open access: yesESC Heart Failure, EarlyView.
Abstract Background Cardiac resynchronization therapy (CRT) is a key intervention for patients with heart failure. The choice between a CRT with defibrillator therapy (CRT‐D) and a CRT with pacemaker (CRT‐P) is influenced by individual clinical characteristics.
Bert Vandenberk   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy